Biotechnology

Sometimes called molecular photocopying, the polymerase chain reaction (PCR) is a fast and inexpensive technique used to amplify – copy – small segments of DNA. PCR is valuable in a number of laboratory and clinical techniques, including DNA fingerprinting, detection of bacteria or viruses, and diagnosis of genetic disorders. According to StrategyHelix, the global polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market is expected to increase by US$ 2,037.6 million during 2022-2028, expanding at a CAGR of 8.5% during the forecast period. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.